TAK-875(Fasiglifam)

  Cat. No.:  DC5073   Featured
TAK-875(Fasiglifam)
Chemical Structure
1000413-72-8
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
TAK-875 is a potent, selective and orally bioavailable GPR40 agonist with EC50 of 0.072 μM.
Cas No.: 1000413-72-8
Chemical Name:
Synonyms: TAK-875; TAK875; TAK 875.
SMILES: CC1=C(C(C)=CC(OCCCS(C)(=O)=O)=C1)C2=CC(COC3=CC=C4[C@@H](COC4=C3)CC(O)=O)=CC=C2
Formula: C29H32O7S
M.Wt: 524.63
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Publication:
Description: TAK-875 is a potent, selective, and orally bioavailable GPR40 agonist, with a pharmacokinetic profile enabling long-acting drug efficacy. TAK-875 showed potent plasma glucose-lowering action and insulinotropic action during an oral glucose tolerance test in female Wistar fatty rats with impaired glucose tolerance. TAK-875 is currently in clinical trials For the treatment of type 2 diabetes mellitus.
In Vivo:
In Vitro:
References:
Kinase Assay:
Cell Assay:
Animal Administration:
References:
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
Cat. No. Product name Field of application
DC5073 TAK-875(Fasiglifam) TAK-875 is a potent, selective and orally bioavailable GPR40 agonist with EC50 of 0.072 μM.